| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/28/2002 | WO2002016380A1 New macrolides with antibacterial activity |
| 02/28/2002 | WO2002016371A1 Penicillin crystal and process for producing the same |
| 02/28/2002 | WO2002016370A1 1h-imidazopyridine derivatives |
| 02/28/2002 | WO2002016368A1 Process for the preparation and purification of thiol-containing maytansinoids |
| 02/28/2002 | WO2002016359A1 Fused pyrazole derivatives being protein kinase inhibitors |
| 02/28/2002 | WO2002015940A2 Solution of an oxazolidinone antibiotic drug |
| 02/28/2002 | WO2002015936A1 Antifungal ketoconazole composition for topical use |
| 02/28/2002 | WO2002015931A1 Immunologic method for the prevention of dental caries |
| 02/28/2002 | WO2002015928A1 METHOD OF ADMINISTERING FimH PROTEIN AS A VACCINE FOR URINARY TRACT INFECTIONS |
| 02/28/2002 | WO2002015923A1 Orally administered peptides to ameliorate atherosclerosis |
| 02/28/2002 | WO2002015920A2 Treatment of hyperproliferative diseases |
| 02/28/2002 | WO2002015917A1 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 02/28/2002 | WO2002015908A1 Injections |
| 02/28/2002 | WO2002015904A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| 02/28/2002 | WO2002015896A2 Methods and compositions for potentiating antibiotic action against persistent/tolerant pathogenic microorganisms |
| 02/28/2002 | WO2002015888A1 Drug-release controlling system |
| 02/28/2002 | WO2002015879A1 A method of treating a systemic disease |
| 02/28/2002 | WO2002015878A1 Aqueous suspension preparations |
| 02/28/2002 | WO2002015867A1 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations |
| 02/28/2002 | WO2002015866A2 Use of cyclic 2,4-diphosphoglycerates (cdgp) and/or derivatives thereof in cosmetic and dermatological formulations |
| 02/28/2002 | WO2002015842A2 Process for preparation of anhydrous azithromycin |
| 02/28/2002 | WO2002015832A1 Non-hormonal vaginal contraceptive |
| 02/28/2002 | WO2002015722A2 Treatment of helicobacter with isothiocyanates |
| 02/28/2002 | WO2002015661A2 Inhibitors of hiv replication and method of treatment of hiv infections |
| 02/28/2002 | WO2002009667A9 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/28/2002 | WO2001087234A3 Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085699A3 Prodrugs of hiv replication inhibiting pyrimidines |
| 02/28/2002 | WO2001083747A3 Prion proteins and their uses |
| 02/28/2002 | WO2001083385A3 Devices and method for production of traceable immunizing drinking water, other liquids and gas |
| 02/28/2002 | WO2001081380A3 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079216A3 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 02/28/2002 | WO2001079167A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/28/2002 | WO2001078767A3 Pharmaceutical preparations comprising modified peptides |
| 02/28/2002 | WO2001076530A3 Il-8 receptor antagonists |
| 02/28/2002 | WO2001073029A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/28/2002 | WO2001070984A3 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 02/28/2002 | WO2001060849A3 Cold-adapted equine influenza viruses |
| 02/28/2002 | WO2001058936A3 Constructs for delivery of therapeutic agents to neuronal cells |
| 02/28/2002 | WO2001049309A3 Combinations of growth factors and i: upa or i: mmp for the treatment of damaged tissue |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | WO2001045661A3 Cosmetic and/or pharmaceutical preparations |
| 02/28/2002 | WO2001042216A3 Caspase inhibitors and uses thereof |
| 02/28/2002 | WO2001032851A3 Modular transport systems for molecular substances and production and use thereof |
| 02/28/2002 | WO2001030812A3 Activation of hcv-specific t cells |
| 02/28/2002 | WO2001027261A3 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 02/28/2002 | WO2001023414B1 Immunologically significant herpes simplex virus antigens |
| 02/28/2002 | WO2001017614A3 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 02/28/2002 | US20020026056 Substituted imidazoles having cytokine inhibitory activity |
| 02/28/2002 | US20020026038 Slurrying a solid comprising clarithromycin Form 0 in water; macrolide antibiotic related to erythromycin A |
| 02/28/2002 | US20020025980 Single morphic forms of metalloproteinase inhibitors |
| 02/28/2002 | US20020025960 Heterocycle carboxamides as antiviral agents |
| 02/28/2002 | US20020025959 Heterocycle carboxamides as antiviral agents |
| 02/28/2002 | US20020025954 Beta-lactamase inhitiors |
| 02/28/2002 | US20020025943 Nucleoside analog compositions and uses thereof |
| 02/28/2002 | US20020025938 Bactericides |
| 02/28/2002 | US20020025935 Antiinflammatory agents; autoimmune diseases; central nervous system disorders |
| 02/28/2002 | US20020025924 Novel lipopeptides as antibacterial agents |
| 02/28/2002 | US20020025919 Antiviral linear polymers |
| 02/28/2002 | US20020025536 Methods and reagents for isolating biologically active antibodies |
| 02/28/2002 | US20020025348 Treatment for inflammatory bowel disease (IBD) and related conditions |
| 02/28/2002 | US20020025344 As antimicrobial agent |
| 02/28/2002 | US20020025329 For immunization |
| 02/28/2002 | US20020025328 As vaccines for immunization |
| 02/28/2002 | US20020025325 Mixing a water soluble palatable flavorant with a water soluble vehicle for administration of an orally administered vaccine admixing with an antigen selected from bacterium and a virus as an active component; administering to animal |
| 02/28/2002 | US20020025304 Novel interferon for the treatment of multiple sclerosis |
| 02/28/2002 | US20020023877 Methods for the production of D-chiro-inositol and the use of D-chiro-inositol obtained therefrom |
| 02/28/2002 | DE10040174A1 Treatment of coccidiosis comprises administration of haloalkylsulfonyl substituted phenoxyphenyl-triazinetrione derivatives |
| 02/28/2002 | DE10040105A1 Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften Peptide and peptidomimetic derivatives having integrin inhibitor properties |
| 02/28/2002 | DE10030318C1 Arzneimittelverpackung für die Eradikationstherapie Drug packaging for the eradication |
| 02/28/2002 | CA2678754A1 Process for the preparation and purification of thiol-containing maytansinoids |
| 02/28/2002 | CA2420477A1 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 02/28/2002 | CA2420261A1 Genes and proteins, and their uses |
| 02/28/2002 | CA2420234A1 Method of administering fimh protein as a vaccine for urinary tract infections |
| 02/28/2002 | CA2420179A1 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | CA2420024A1 Fused pyrazole derivatives being protein kinase inhibitors |
| 02/28/2002 | CA2419915A1 New sequences |
| 02/28/2002 | CA2419873A1 Process for preparation of anhydrous azithromycin |
| 02/28/2002 | CA2419840A1 Treatment of hyperproliferative diseases |
| 02/28/2002 | CA2419597A1 Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading |
| 02/28/2002 | CA2416748A1 Improved specificity in treatment of diseases |
| 02/28/2002 | CA2415793A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| 02/28/2002 | CA2386083A1 Penicillin crystal and process for producing the same |
| 02/27/2002 | EP1182206A2 Stabilized oligonucleotids and the use thereof |
| 02/27/2002 | EP1182204A1 Crystals of carbapenem derivatives and pharmaceutical preparations for injection |
| 02/27/2002 | EP1182202A1 Aminomethylpyrrolidine derivatives having aromatic substituents |
| 02/27/2002 | EP1182195A1 Cyclic compounds and uses thereof |
| 02/27/2002 | EP1181393A2 CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L11/GTPASE ACTIVATING REGION rRNA AND USES THEREOF |
| 02/27/2002 | EP1181390A1 27 human secreted proteins |
| 02/27/2002 | EP1181385A2 Modulation of gene expression in gastrointestinal inflammation |
| 02/27/2002 | EP1181381A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 02/27/2002 | EP1181367A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
| 02/27/2002 | EP1181363A1 Recombinant human mannan-binding lectin |
| 02/27/2002 | EP1181320A2 Somatic transgene immunization and related methods |
| 02/27/2002 | EP1181316A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
| 02/27/2002 | EP1181314A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations |
| 02/27/2002 | EP1181313A2 Peptides for vaccinating against human cmv |